Project milestone Open Access
{ "inLanguage": { "alternateName": "eng", "@type": "Language", "name": "English" }, "description": "<p>Macrodomain is a compelling target for SARS-CoV-2, but there are no inhibitors (or even starting points for inhibitors). The QCRG Structural Biology Consortium performed a crystallographic fragments screen, identifying a few small molecules to kick-start our work to develop an inhibitor. Our friends in the UK, Ivan Ahel’s lab and X-Chem, <a href=\"https://www.diamond.ac.uk/covid-19/for-scientists/SARS-CoV-2-macrodomain.html\">did something similar</a> and found even more fragment starting points. We are releasing <a href=\"https://fragalysis.diamond.ac.uk/viewer/react/preview/target/mArh\">the data together</a>!</p>\n\n<p>This record (see README file) has the data available here: <a href=\"https://fraserlab.com/macrodomain/\">https://fraserlab.com/macrodomain/</a> and published here: https://pubmed.ncbi.nlm.nih.gov/33853786/ </p>", "license": "https://creativecommons.org/licenses/by/4.0/legalcode", "creator": [ { "affiliation": "UCSF/QCRG", "@id": "https://orcid.org/0000-0002-5080-2859", "@type": "Person", "name": "James S Fraser" } ], "url": "https://zenodo.org/record/4716363", "datePublished": "2021-04-23", "keywords": [ "coronavirus", "macrodomain", "fragment screening", "X-ray crystallography" ], "version": "2.0", "contributor": [ { "affiliation": "UCSF", "@type": "Person", "name": "QBI Coronavirus Research Group Structural Biology Consortium" } ], "@context": "https://schema.org/", "identifier": "https://doi.org/10.5281/zenodo.4716363", "@id": "https://doi.org/10.5281/zenodo.4716363", "@type": "CreativeWork", "name": "Identifying new ligands for the SARS-CoV-2 Macrodomain by Fragment Screening and Multi-temperature Crystallography" }
All versions | This version | |
---|---|---|
Views | 2,207 | 1,187 |
Downloads | 295 | 51 |
Data volume | 53.1 GB | 13.3 GB |
Unique views | 2,025 | 1,091 |
Unique downloads | 140 | 40 |